Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aluminum sulphate + zinc sulphate + benzocaine + chlorhexidine + titanium dioxide is a topical multi-ingredient perianal ointment investigated by the Pontifical Catholic University of Chile (Pontificia Universidad Católica de Chile) for the treatment of faecal incontinence in adult women. The formulation combines astringent agents (aluminum sulphate and zinc sulphate), a local anaesthetic (benzocaine), an antiseptic/antimicrobial agent (chlorhexidine), and a physical barrier/protective agent (titanium dioxide). It acts locally on perianal tissue to reduce symptoms of faecal incontinence, potentially by increasing the tone or contraction strength of the anal sphincter. It was evaluated in a completed outpatient clinical trial comparing the ointment versus a placebo base cream over 4 weeks, with efficacy measured by the Wexner Score and Faecal Incontinence Quality of Life scale.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aluminum sulphate + zinc sulphate + benzocaine + chlorhexidine + titanium dioxide.